GROWTH OF PREMATURE INFANTS/ROSS SSC FORMULA STUDY

早产儿的生长/ROSS SSC 配方研究

• 批准号: 6295082
• 负责人: REGINALD C TSANG
• 金额: $ 3.1万
• 依托单位: CINCINNATI CHILDRENS HOSP MED CTR
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-12-01 至 1999-11-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6295082
• 关键词: baby food; body weight; bone metabolism; child physical development; clinical research; developmental nutrition; dietary iron; human subject; normal ossification; nutrition related tag; premature infant human

The primary objective of this study is to determine if feeding preterm infants Reformulated Similac Special Care (RSSC) in-hospital and a specialized premature infant discharge formula (PDF) after hospital discharge will result in better bone mineralization compared to feeding Similac Special Care (SSC) in-hospital and Similac with Iron (SWI) after discharge. The secondary objective is to determine if there will be greater growth. The null hypothesis to be tested is that infants receiving RSSC in-hospital and PDF after discharge will not differ in bone mineral content (BMC) or growth from those fed SSC in-hospital and SWI after discharge, the current standard regimen.

本研究的主要目的是确定与院内喂养Similac Special Care （SSC）和出院后喂养Similac Special Care （SWI）相比，院内喂养Similac Special Care （SSC）和出院后喂养Similac with Iron （SWI）是否会导致更好的骨矿化。第二个目标是确定是否会有更大的增长。待检验的零假设是，在出院后接受RSSC和PDF的婴儿与在出院后接受SSC和SWI（目前的标准方案）的婴儿在骨矿物质含量（BMC）或生长方面没有差异。